Environmental Analysis Health and Toxicology

The Korean Society of Environmental Health and Toxicology (환경독성보건학회)
권호 표지

Effects of Dextromethorphan on the Primary Humoral Immune Response in Mice

덱스트로메트르판이 마우스의 일차 체액성 면역반응에 미치는 영향

  • 표명윤 (숙명여자대학교 약학대학)
  • Published : 2006.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Dextromethorphan hydrobromide (DXM) has been widely used as a nonopioid antitussive drug with low toxicity and low potential for drug dependency. DXM is a psychotropic drug since 2003 in our country. This study was performed to investigate the immunotoxicity induced by abuse of DXM. Mice were orally exposed to DXM dissolved in saline as concentration of 30, 60, and 120 mg/kg b.w. before (day-2) or after (day+2) immunization (OVA-antigen, day 0). Thereafter, we measured the increased rate of body weight, relative weight of organ (thymus, spleen, liver, kidney) and OVA-specific IgM level in sera. In addition, mouse splenocytes were exposed to various concentration of DXM $(0.001{\sim}100{\mu}M)$ and cultured with B cell mitogen (LPS) and splenocytes proliferations (SP) were measured by MTT-assay. Thymus-weight were slightly changed on day 9 after administration of DXM, but body-, spleen-, liver-, and kidney-weight were not different between control group and DXM-treated group. SP to LPS were significantly decreased at high concentration $(100{\mu}M)$ when compared with controls. When DXM was administered before or after immunization with OVA-antigen, OVA-specific IgM levels were significantly lowered in a dose-dependent manner. These results indicate that DXM nay depress the primary humoral immune response to the initial antigenic challenge.

Keywords

References

  1. Bem JL and Peck R. Dextromethorphan; An overview of safty issues, Drug Saf. 1992; 7(3): 190-199 https://doi.org/10.2165/00002018-199207030-00004
  2. Bryner JK, Wang UK, Hui JW, Bedodo M and Macdougall C, Anderson IB. Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004, Arch Pediatr Adolesc Med 2006; 160(12): 1217-1222 https://doi.org/10.1001/archpedi.160.12.1217
  3. Chung H, Park M, Hahn E, Choi H, Choi H and Lim M. Recent trends of drug abuse and drug-associated deaths in Korea, Ann N Y Acad Sci 2004; 1025: 458-464 https://doi.org/10.1196/annals.1316.056
  4. Ciapetti G, Cenni E, Pratelli L and Pizzoferrato A. In vitro evaluation of cell/biomaterial interaction by MTT assay, Biomaterial 1993; 14(5): 359-364 https://doi.org/10.1016/0142-9612(93)90055-7
  5. Constanzer ML, Chavez-Eng CM, Fu I, Woolf EJ and Matuszewsk BK. Determination of dextromethorphan and its metabolite dextrorphan in human urine using high performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry: a study of selectivity of a tandem mass spectrometric assay, J Chromatogr B Analyt Technol Biomed Life Sci 2005; 816(1-2): 297-308 https://doi.org/10.1016/j.jchromb.2004.04.020
  6. Descotes J. Immunotoxicology of drugs and chemicals: An experimental and clinical approach, Volume I. Principles and methods of immunotoxicology, 3rd ed. 2004; 46-48
  7. Di Francesco P, Gaziano R, Pica F, Palamara AT, Innocenti F and Favalli C. In vitro phencyclidine-induced inhibition of lymphocyte proliferation: prevention by cell activation, Immunopharmacol Immunotoxicol 1993; 15(1): 69-78 https://doi.org/10.3109/08923979309066934
  8. Engvall E and Perlmann P. Enzyme-linked immunosorbent assay, ELISA. J Immunol 1972; 109(1): 129-135
  9. Kaminski NE. Mechanism of immune modulation by cannabinoids, in Dean JH, Luster MI, Munson AE, Kimber I (eds): Immunotoxicology and Immunopharmacology, 2d ed. New York: Raven Press, 1994; 349-362
  10. Kim EM, Lee JS, Park MJ, Choi SK, Lim MA and Chung HS. Standardization of method for the analysis of dextromethorphan in urine, Forensic Sci Int 2006; 161(2-3): 198-201 https://doi.org/10.1016/j.forsciint.2005.12.034
  11. Kim HC, Jhoo WK, Kwan MS and Hong JS. Effects of Chronic Dextromethorphan Administrationon the Cellular Immune Responses in Mice, Archives of Pharmacal Research 1995; 18(4): 267-270 https://doi.org/10.1007/BF02976411
  12. LeVier DG, McCay JA and Stern ML. Immunotoxicological profile of morphine sulfate in B6C3F1 mice, Fundam Appl Toxicol 1994; 22: 525-542 https://doi.org/10.1006/faat.1994.1060
  13. Manaboriboon B and Chomchai C. Dextromethorphan abuse in Thai adolescents: A report of two cases and review of literature, Med Assoc Thai 2005; 88 Suppl 8: S242-245
  14. Matveyeva M, Hartman CB and Harrison MT. Delta (9)-tetrahydrocannabinol selectively increases aspartyl cathepsin D proteolytic activity and impairs lysozomal processing in macrophages, Int J Immunopharmacol 2000; 22(5): 373-381 https://doi.org/10.1016/S0192-0561(99)00092-2
  15. Mischell B and Shiigi S. Selected methods in cellular immunology, WH Freman and company 1980; 16: 14-17
  16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J Immunol Methods 1983; 65: 55-63 https://doi.org/10.1016/0022-1759(83)90303-4
  17. Pecknick RN and Poland RE: Comparison of the effects of dextromethorphan, dextrophan, and levorphanol on the hypothalamo-pituitary-adrenal axis, J Pharmacol Exp Ther 2004; 309(2): 515-522 https://doi.org/10.1124/jpet.103.060038
  18. Schwartz RH. Adolescent abuse of dextromethorphan, Clin Pediatr (Phila) 2005; 44(7): 565-568 https://doi.org/10.1177/000992280504400702
  19. Shin EJ, Nabeshima T, Lee PH, Kim WI, Ko KH, Jhoo JH, Jhoo WK, Cha JY and Kim HC. Dimermorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice, Behv Brain Res 2004; 151: 267-276 https://doi.org/10.1016/j.bbr.2003.09.004
  20. Smialowicz RJ and Holsapple MP. Experimental Immunotoxicology, Boca Raton, FL : CRC Press, 1996; 13-15
  21. Wu D, Chon V, Kalow W and Sellers EM. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat, J Pharmacol Exp Ther 1995; 274: 1431-1437
  22. Yoo Y, Chung H, Kim E and Kim M. Fetal zipeprol and dextromethorphan poisonings in Korea, J Anal Toxicol 1996; 20(3): 155-158 https://doi.org/10.1093/jat/20.3.155
  23. Yun HE and Pyo MY. Effects of nalbuphine on the primary humoral immune, J Environ Toxicol 2005; 20(4): 343-350
  24. Ziaee V, Akbari Hamed E, Hoshmand A, Amini H, Kebriaeizadeh A and Saman K. Side effects of dextromethorphan abuse, a case series, Addict Behav 2005; 30(8): 1607-1613 https://doi.org/10.1016/j.addbeh.2005.02.005